ACADIA PHARMACEUTICALS INC's ticker is and the CUSIP is 004225958. A total of 4 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $300,625 | -98.3% | 18,500 | -98.0% | 0.00% | -100.0% |
Q1 2024 | $17,190,153 | +586.3% | 929,700 | +1062.1% | 0.00% | +300.0% |
Q4 2023 | $2,504,800 | -79.4% | 80,000 | -86.3% | 0.00% | -75.0% |
Q3 2023 | $12,153,888 | +4924.4% | 583,200 | +5674.3% | 0.00% | – |
Q2 2023 | $241,895 | +21.3% | 10,100 | -4.7% | 0.00% | – |
Q1 2023 | $199,492 | +13.9% | 10,600 | -3.6% | 0.00% | – |
Q4 2022 | $175,120 | -88.6% | 11,000 | -88.3% | 0.00% | -100.0% |
Q3 2022 | $1,538,000 | -45.7% | 94,000 | -53.2% | 0.00% | 0.0% |
Q2 2022 | $2,832,000 | – | 201,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 4,175 | $14,884,000 | 0.82% |
SIMPLEX TRADING, LLC | 399 | $95,000 | 0.01% |
Citadel Advisors | 76,700 | $2,734,000 | 0.00% |